• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

No­vavax and Cure­Vac among sev­er­al biotechs with new CEOs; Michel Vounatsos, John Tsai land board ap­point­ments

3 years ago
Peer Review

Dig­i­tal ther­a­peu­tics 2023: Swing and tri­al part­ner Cu­rav­it kick off fi­bromyal­gia study

3 years ago
Pharma
Marketing

Three Ohio-based con­tract or­ga­ni­za­tions win $149M deal for neu­ro­log­i­cal can­di­dates

3 years ago
Deals
Outsourcing

As­traZeneca to dis­con­tin­ue rare blood can­cer drug in the US

3 years ago
Pharma
FDA+

Gal­der­ma dri­ves di­ver­si­ty in der­ma­tol­ogy with on­line pho­to gallery spon­sor­ship

3 years ago
Pharma
Marketing

Alex Den­ner tar­gets Amarin, de­mand­ing board chair re­sign in call for share­hold­er meet­ing

3 years ago
People

Pfiz­er, BioN­Tech team up with Martha Stew­art for Covid boost­er cam­paign

3 years ago
Pharma
Marketing

Li­nus­Bio se­cures Se­ries A for di­ag­nos­tic plat­form that us­es a sin­gle strand of hair

3 years ago
Financing

A Take­da-backed GI and pain biotech qui­et­ly shut­ters

3 years ago
People
Startups

Man­u­fac­tur­ing roundup: Cy­ti­va part­ners with Au­risco to build site for oligonu­cleotides; Eu­roAPI in­vest­ing €40M to ...

3 years ago
Manufacturing

Q&A: Can in­haled vac­cines mount come­back for one-time leader in Chi­na's Covid race?

3 years ago
People
China

WHO is­sues alert over con­t­a­m­i­nat­ed cough syrups

3 years ago
Pharma
Manufacturing

Oramed’s in­sulin pill fails PhI­II tri­al in di­a­betes, stock craters

3 years ago
R&D

Cam­bri­an's an­ti-ag­ing mis­sion ex­pands with new fi­brot­ic dis­ease biotech

3 years ago
Startups

Scoop: Biotech de­vel­op­ing oral Alzheimer's drug is on $50M hunt

3 years ago
Financing
Startups

Google health tech spin­out Ver­i­ly lays off staff amid ex­ec de­par­tures

3 years ago
People

Leg­is­la­tors call HHS to ac­tion on Xtan­di march-in rights

3 years ago
Pharma

Con­tract man­u­fac­tur­er nets cap­i­tal in­vest­ment to ex­pand its phys­i­cal space and in­stall a new fill-fin­ish line

3 years ago
Manufacturing

Ex­perts talk IRA im­pacts as CMS an­nounces it will pub­lish first 10 drugs up for ne­go­ti­a­tion in Sep­tem­ber

3 years ago
R&D
Pharma

Cannes Li­ons names ju­ry chiefs for 2023 ad cre­ativ­i­ty show, Om­ni­com and VM­LY&R ex­ecs helm health pan­els

3 years ago
Pharma
Marketing

Sun Phar­ma fa­cil­i­ty un­der an im­port alert hand­ed a warn­ing let­ter

3 years ago
Pharma
FDA+

Mer­ck leads bio­phar­mas in an­nu­al ‘just’ busi­ness rank­ing, while GSK and Sanofi nab sus­tain­abil­i­ty hon­ors

3 years ago
Pharma
Marketing

ICY­MI: 'What could they pos­si­bly buy?' Sanofi's Paul Hud­son talks M&A hes­i­ta­tion at #JPM23

3 years ago
Deals
Pharma

Q&A: How to at­tract the eye of an ear­ly in­vestor in biotech R&D tools

3 years ago
Financing
First page Previous page 391392393394395396397 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.